Zomedica Corp. (NYSEAMERICAN:ZOM - Get Free Report)'s stock price dropped 2.8% during mid-day trading on Wednesday . The company traded as low as $0.12 and last traded at $0.12. Approximately 5,779,875 shares traded hands during mid-day trading, an increase of 20% from the average daily volume of 4,808,725 shares. The stock had previously closed at $0.12.
Wall Street Analyst Weigh In
Separately, Noble Financial raised Zomedica to a "strong-buy" rating in a report on Monday, November 11th.
Check Out Our Latest Stock Report on ZOM
Zomedica Stock Up 1.7 %
The firm has a market cap of $117.59 million, a P/E ratio of -2.00 and a beta of 1.04.
Hedge Funds Weigh In On Zomedica
An institutional investor recently bought a new position in Zomedica stock. Jane Street Group LLC acquired a new position in shares of Zomedica Corp. (NYSEAMERICAN:ZOM - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 179,074 shares of the company's stock, valued at approximately $25,000. 8.95% of the stock is owned by institutional investors and hedge funds.
About Zomedica
(
Get Free Report)
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system.
Featured Articles
Before you consider Zomedica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zomedica wasn't on the list.
While Zomedica currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
